Novo Nordisk stock jumped Monday after the FDA approved the company's obesity drug, Wegovy, as a treatment for MASH.

Investors eyed risks around a high-stakes US-Ukraine meeting, kicking off a week dominated by a Federal Reserve speech that ...

In front of a sold-out Richmond Raceway crowd, the NASCAR Cup Series put on a show on Saturday night with tire wear. Austin ...